Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic interventionPeter L. Pedersen, Young Hee Ko, Annette Rempel et al.|Biochimica et Biophysica Acta (BBA) - Bioenergetics|2002Cited by 350
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinaseYoung Hee Ko, J.F. Geschwind, Peter L. Pedersen|Cancer Letters|2001Cited by 346
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.J.F. Geschwind, Peter L. Pedersen, Young Hee Ko et al.|PubMed|2002Cited by 257